Cite
HARVARD Citation
Chiba, Y. et al. (2020). Hyper‐progressive disease after immune checkpoint inhibitor in SMARCA4‐deficient small‐cell lung carcinoma. Respirology case reports. 8 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chiba, Y. et al. (2020). Hyper‐progressive disease after immune checkpoint inhibitor in SMARCA4‐deficient small‐cell lung carcinoma. Respirology case reports. 8 (8), p. n/a. [Online].